Vrisha Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.96 Cr
- Satisfied Charges ₹ 3.67 Cr
- Revenue Growth 497.14%
- Profit Growth 79.36%
- Ebitda 195.65%
- Net Worth -3.58%
- Total Assets -18.81%
About Vrisha Pharmaceuticals
Vrisha Pharmaceuticals Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 October 2005 and has a history of 19 years and three months. Its registered office is in Navi Mumbai, Maharashtra.
The Corporate was formerly known as Vrisha Pharmaceticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.96 Cr. The company has closed loans amounting to ₹3.67 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jagdish Chaudhari, Rajendra Apandkar, and Sajid Asfi serve as directors at the Company.
Company Details
-
LocationNavi Mumbai, Maharashtra
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U52310MH2005PTC156801
-
Company No.
156801
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Oct 2005
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Vrisha Pharmaceuticals?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rajendra Apandkar | Director | 13-Dec-2017 | Current |
Jagdish Chaudhari | Additional Director | 17-Dec-2021 | Current |
Sajid Asfi | Director | 20-May-2018 | Current |
Financial Performance of Vrisha Pharmaceuticals.
Vrisha Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 497.14% increase. The company also saw a substantial improvement in profitability, with a 79.36% increase in profit. The company's net worth dipped by a decrease of 3.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Vrisha Pharmaceuticals?
Unlock access to Vrisha Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹29.55 M
₹36.70 M
Charges Breakdown by Lending Institutions
- Others : 2.01 Cr
- Axis Bank Limited : 0.95 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
22 Jul 2016 | Others | ₹2.01 Cr | Open |
21 Feb 2011 | Axis Bank Limited | ₹9.50 M | Open |
23 Sep 2013 | Icici Bank Limited | ₹1.77 Cr | Satisfied |
16 May 2012 | First Blue Home Finance Limited | ₹4.00 M | Satisfied |
22 Feb 2011 | Standard Chartered Bank | ₹1.50 Cr | Satisfied |
How Many Employees Work at Vrisha Pharmaceuticals?
Unlock and access historical data on people associated with Vrisha Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vrisha Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vrisha Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.